<DOC>
	<DOC>NCT00362726</DOC>
	<brief_summary>The purpose of this clinical research study is to assess the effect of Atazanavir 400 mg QD and Atazanavir/Ritonavir 300/100 mg QD at steady state on the single dose pharmacokinetics of RGZ in healthy subjects.</brief_summary>
	<brief_title>Drug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate Rosiglitazone</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<criteria>Healthy male and female subjects between the ages 18 to 50 years old with a BMI 18 to 32 kg/m2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>HIV</keyword>
</DOC>